Proton-pump inhibitors
Proton-pump inhibitors (PPIs) are a class of drugs that profoundly suppress gastric acid secretion, and thus have become the treatment of choice for gastro-oesophageal reflux disease and peptic ulcer disease. PPIs are considered safe and effective. It is essential that clinicians understand the appr...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2015-05-01
|
| Series: | South African Family Practice |
| Subjects: | |
| Online Access: | https://safpj.co.za/index.php/safpj/article/view/4288 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849737496201527296 |
|---|---|
| author | Vasudevan G. Naidoo |
| author_facet | Vasudevan G. Naidoo |
| author_sort | Vasudevan G. Naidoo |
| collection | DOAJ |
| description | Proton-pump inhibitors (PPIs) are a class of drugs that profoundly suppress gastric acid secretion, and thus have become the treatment of choice for gastro-oesophageal reflux disease and peptic ulcer disease. PPIs are considered safe and effective. It is essential that clinicians understand the appropriate use of PPIs, given the significant economic burden of inappropriate prescribing and safety concerns. Long-term safety concerns and possible drug interactions have led to a more conservative approach to PPI use. Some of these concerns may have been overstated, but they serve to highlight the need for ongoing vigilance because even a small increased risk of an adverse event may translate to a large number, considering that the use of PPIs is widespread. This review focuses on the use of oral PPIs in the ambulatory setting, and recent concerns regarding the adverse effects of PPIs. |
| format | Article |
| id | doaj-art-3de6f6272bb642bab47d7ed3cfb7e249 |
| institution | DOAJ |
| issn | 2078-6190 2078-6204 |
| language | English |
| publishDate | 2015-05-01 |
| publisher | AOSIS |
| record_format | Article |
| series | South African Family Practice |
| spelling | doaj-art-3de6f6272bb642bab47d7ed3cfb7e2492025-08-20T03:06:54ZengAOSISSouth African Family Practice2078-61902078-62042015-05-0157310.4102/safp.v57i3.42883464Proton-pump inhibitorsVasudevan G. Naidoo0Department of Gastroenterology, University of KwaZulu-Natal, South Africa; and Inkosi Albert Luthuli Central HospitalProton-pump inhibitors (PPIs) are a class of drugs that profoundly suppress gastric acid secretion, and thus have become the treatment of choice for gastro-oesophageal reflux disease and peptic ulcer disease. PPIs are considered safe and effective. It is essential that clinicians understand the appropriate use of PPIs, given the significant economic burden of inappropriate prescribing and safety concerns. Long-term safety concerns and possible drug interactions have led to a more conservative approach to PPI use. Some of these concerns may have been overstated, but they serve to highlight the need for ongoing vigilance because even a small increased risk of an adverse event may translate to a large number, considering that the use of PPIs is widespread. This review focuses on the use of oral PPIs in the ambulatory setting, and recent concerns regarding the adverse effects of PPIs.https://safpj.co.za/index.php/safpj/article/view/4288proton-pump inhibitorsppisgastro-oeseophageal reflux diseasegordpud |
| spellingShingle | Vasudevan G. Naidoo Proton-pump inhibitors South African Family Practice proton-pump inhibitors ppis gastro-oeseophageal reflux disease gord pud |
| title | Proton-pump inhibitors |
| title_full | Proton-pump inhibitors |
| title_fullStr | Proton-pump inhibitors |
| title_full_unstemmed | Proton-pump inhibitors |
| title_short | Proton-pump inhibitors |
| title_sort | proton pump inhibitors |
| topic | proton-pump inhibitors ppis gastro-oeseophageal reflux disease gord pud |
| url | https://safpj.co.za/index.php/safpj/article/view/4288 |
| work_keys_str_mv | AT vasudevangnaidoo protonpumpinhibitors |